UCB Pharma SA — China registrations and re-registration filing lines
13 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest filing line: 2028-04-18.
| Approval number | Product | Certificate expires | Filing line (Art. 82) |
|---|---|---|---|
| 国药准字HJ20180062 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20180063 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20180064 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20180065 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20180069 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20180070 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20180071 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20180072 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20191025 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字HJ20191026 | VIMPAT 拉考沙胺片 | 2028-10-18 | 2028-04-18 |
| 国药准字SJ20190031 | Cimzia 培塞利珠单抗注射液 | 2029-03-24 | 2028-09-24 |
| 国药准字HJ20190060 | VIMPAT 拉考沙胺注射液 | 2029-11-06 | 2029-05-06 |
| 国药准字HJ20200021 | VIMPAT 拉考沙胺口服溶液 | 2030-06-12 | 2029-12-12 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.